Latest News and Press Releases

Chengdu Origen and Vanotech Announce First Patient Dosed in VAN-2401 Phase 1 Trial of Gene Therapy for Wet Age-Related Macular Degeneration

Austin, TX, USA, April 30, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Multi Cancer Early Detection Market Size, Trends and Insights By Type (Liquid...

Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer

Genetic Technologies Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer

MILAN, Italy and NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinical-stage immuno-oncology company developing a cell-based platform harnessing the power...

GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year

GTG Global Collaborations and Innovation Update

STEVENAGE, United Kingdom, March 26, 2024 (GLOBE NEWSWIRE) -- Laverock Therapeutics, a gene-silencing company with a uniquely powerful technology for the development of programmable advanced...

MELBOURNE, Australia, March 25, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE, “Company”, “GENE”), a global leader in guideline-driven genomics-based testing in health, wellness...

MELBOURNE, Australia, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, “Company”, “GTG”), is pleased to announce the launch of a wide-reaching customer – targeted...